Propensity score analysis of a six-year experience with minimally invasive isolated aortic valve replacement

Ram Sharony1, Eugene A Grossi, Paul C Saunders

  • 1Division of Cardiothoracic Surgery, Department of Surgery, New York University School of Medicine, New York, USA.

Abstract

Insights

Minimally invasive aortic valve replacement (MIAVR) offers similar safety and effectiveness to standard sternotomy (SS) for aortic valve replacement. MIAVR leads to shorter hospital stays and more direct home discharges, improving patient recovery outcomes.

Area of Science:

  • Cardiovascular Surgery
  • Minimally Invasive Procedures
  • Aortic Valve Replacement

Background:

  • Minimally invasive aortic valve replacement (MIAVR) is an emerging technique requiring further outcome validation.
  • Non-randomized treatment comparisons necessitate advanced statistical methods like propensity score matching.
  • Evaluating MIAVR against standard sternotomy (SS) is crucial for establishing its clinical utility.

Purpose of the Study:

  • To compare the outcomes of MIAVR versus standard sternotomy (SS) for isolated aortic valve replacement (AVR).
  • To utilize propensity score analysis to mitigate bias in a non-randomized study design.
  • To assess hospital mortality, major morbidity, length of stay, and discharge destination.

Main Methods:

  • Propensity score matching was used to create two comparable cohorts of 233 patients each from a total of 921 isolated AVR patients.
  • Matching criteria included numerous risk factors such as ejection fraction, comorbidities, and urgency of operation.
  • Data were collected prospectively between January 1995 and December 2002.

Main Results:

  • Hospital mortality (5.6% vs 7.3%) and major morbidity (13.3% vs 14.2%) were statistically similar between MIAVR and SS groups.
  • Multivariable analysis identified severe atheromatous aortic disease, COPD, and urgent operation as predictors of increased mortality.
  • MIAVR demonstrated a significantly shorter median length of hospital stay (6 vs 8 days) and a higher rate of direct home discharge (65.7% vs 52.9%).

Conclusions:

  • MIAVR is a safe and effective alternative to SS for aortic valve replacement, with comparable mortality and morbidity.
  • The MIAVR approach is associated with significant benefits, including reduced hospital length of stay.
  • Patients undergoing MIAVR have a greater likelihood of being discharged directly home, indicating improved recovery and potentially reduced need for transitional care.

Related Concept Videos